Cargando…
Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia
Intravenous flucloxacillin is one of the most frequently used high‐dose penicillin therapies in hospitalized patients, forming the cornerstone treatment of invasive Staphylococcus aureus infection. Being a nonreabsorbable anion, flucloxacillin has been suggested to cause hypokalaemia, although the f...
Autores principales: | van der Heijden, Charlotte D.C.C., Duizer, Marleen L., Fleuren, Hanneke W.H.A., Veldman, Bart A., Sprong, Tom, Dofferhoff, Anton T.S.M., Kramers, Cornelis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955408/ https://www.ncbi.nlm.nih.gov/pubmed/31026083 http://dx.doi.org/10.1111/bcp.13969 |
Ejemplares similares
-
Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
por: Plantaz, Milan M. E. A., et al.
Publicado: (2020) -
An electronic trigger tool to optimise intravenous to oral antibiotic switch: a controlled, interrupted time series study
por: Berrevoets, Marvin A. H., et al.
Publicado: (2017) -
Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury
por: Ali, Serat-E, et al.
Publicado: (2023) -
Chronic hypokalaemia and nephrocalcinosis
por: Schwedler, Susanne B., et al.
Publicado: (2009) -
Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
por: Boughton, Charlotte, et al.
Publicado: (2018)